You are about to leave the site operated by PT B. Braun Medical Indonesia and be redirected to a site operated by one of its related corporations. The site to which you are redirected, has been designed to comply with the laws of the jurisdiction in which the related corporation operates. It has not been reviewed, and may therefore not, comply with the requirements under Indonesian law. PT B. Braun Medical Indonesia makes no representations as to the accuracy or completeness of any statements contained in the site which you are directed to.

Cancel

We use cookies to enable all functionalities for best performance during your visit and to improve our services by giving us some insight into how the website is being used. Continued use of our website without having changed your browser settings confirms your acceptance of these cookies. For details please see our privacy policy.

You have successfully logged out.

Granisetron B. Braun

Granisetron belongs to the class of 5-HT3- receptor antagonists and effectively controls acute nausea and vomiting evoked by highly and moderately emetogenic chemotherapy regimens. Furthermore, Granisetron prevent radiotherapy-induced nausea and vomiting in patients undergoing moderately and highly emetogenic irradiation therapy.